Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fereshteh, Vaziri Nezamdoust"'
Autor:
Mohammad Danesh-Doust, Rasoul Irajirad, Fereshteh Vaziri Nezamdoust, Sara Khademi, Alireza Montazerabadi
Publikováno v:
Cell Journal, Vol 25, Iss 2, Pp 126-134 (2023)
Objective: Increasing research has been focused on the development of various nanocomplexes as targeted contrastmedia in diagnostic modalities, mainly in computed tomography (CT) scan imaging. Herein, we report a new methodthat uses Triptorelin [a lu
Externí odkaz:
https://doaj.org/article/073219a7d42940309867a93415490b9a
Publikováno v:
International Journal of Reproductive BioMedicine, Vol 21, Iss 1, Pp 33-43 (2023)
Abstract Background: A large proportion of cases of recurrent pregnancy loss (RPL) are associated with immunological factors. Objective: This study investigated the association between single nucleotide polymorphisms of cytotoxic T-lymphocyte-associa
Externí odkaz:
https://doaj.org/article/025094431aa948eeb1d7497f30df03dd
Autor:
Yazdan Choghazardi, Hosein Azimian, Alireza Montazer Abadi, Milad Mohammadi Khoshisani, Fereshteh Vaziri Nezamdoust, Hamid Gholamhosseinian
Publikováno v:
Journal of Nanomaterials. 2023:1-11
The aim of this study was to assess the radiosensitivity of bismuth sulfide nanoparticles conjugated with a synthetic agonist analog of gonadotropin-releasing hormones in targeted radiotherapy for breast cancer. After synthesis and characterization o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7feb78f3622cff981fac7308b805b510
https://doi.org/10.1155/2023/5485632
https://doi.org/10.1155/2023/5485632
Autor:
Farzaneh Ghorbani, Rasoul Irajirad, Farshad Emami, Fereshteh Vaziri Nezamdoust, Alireza Montazerabadi
Publikováno v:
Applied Nanoscience. 12:2291-2304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b52a7db396ea8a6d65e68c232e28c60d
https://doi.org/10.1007/s13204-022-02507-5
https://doi.org/10.1007/s13204-022-02507-5
Autor:
Abolghasem Asadi-Saghandi, Meisam Barati, Akram Astani, Fereshteh Vaziri Nezamdoust, Pourya Raee, Farzaneh Fesahat, Amir Abdian Asl
Publikováno v:
Journal of Obstetrics and Gynaecology. 41:774-778
Natural killer group 2, member D (NKG2D) is one of the best known activating receptors of NK cells, which recognises its ligand on altered or stressed cells and activates NK cells to kill them. In ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::939c1caf3c8d7588f40f56a877a287eb
https://doi.org/10.1080/01443615.2020.1798906
https://doi.org/10.1080/01443615.2020.1798906
Autor:
Amir, Abdian Asl, Fereshteh, Vaziri Nezamdoust, Farzaneh, Fesahat, Akram, Astani, Meisam, Barati, Pourya, Raee, Abolghasem, Asadi-Saghandi
Publikováno v:
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 41(5)
Natural killer group 2, member D (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce4f6993c7a3b48550458a18e663b551
https://pubmed.ncbi.nlm.nih.gov/33063590
https://pubmed.ncbi.nlm.nih.gov/33063590
Autor:
Javad Farhadi, Fereshteh Vaziri Nezamdoust, Mohammad-Taghi Bahreyni-Toossi, Hosein Azimian, Hassan Mehrad-Majd, Navid Zafari
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Introduction: Radiotherapy is a crucial component of treatment for ∼70% of all cancer patients. The identification of effective biomarkers of radiosensitivity (RS) is a fundamental goal of radiobio...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a497690076a3f56a9e5f4ead6fb52c83
https://pubmed.ncbi.nlm.nih.gov/32833505
https://pubmed.ncbi.nlm.nih.gov/32833505